Speaker Profile
M.D., FACP, Center Associate Director, Professor, Medical College of Wisconsin
Biography
Dr. Kurzrock is a boardcertified medical oncologist and a renowned expert in precision medicine. She developed one of the worlds largest Phase I clinical trial programs while at MD Anderson Cancer Center. Dr. Kurzrock also founded the UCSDs Center for Personalized Cancer Therapy, focusing on genomicallydriven therapy as well as precision immunotherapy, especially in rare cancers. Dr. Kurzrock brought the first transcriptomic study to the clinic in an international setting spanning five countries (WINTHER), as well as the first Nof1 study of individually customized combination therapy (IPREDICT). Dr. Kurzrock received her MD from the University of Toronto, Canada. She has 900 PubMed publications, an Hindex of 140, has been named to the lists of most highly cited scientists in the world. She has a uniquely strong record of competitive funding with 100 million dollars in lifetime funding, and has overseen early development of multiple drugs that are now FDA approved.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair: TBA
PMWC Award Ceremony Honorees
• Mark Daly, Broad Institute
• Daniel MacArthur, CPG/Genomes/gnomAD
• Gordon Sanghera, Oxford Nanopore
• Howard J. Jacob, Abbvie
The Data Factory: Building Systems to Integrate Millions of Genomes for Variant Interpretation
• Chair: Stephen B. Montgomery, Stanford
• Carlos D. Bustamante, University of Oklahoma
• Mark Daly, Broad Institute/FinnGen
• Manuel Rivas, Stanford
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley
Biobanks to Bedside: Cutting VUS in Cancer, Cardio & Rare—What’s Working Now
• Chair: Ben Neale, Broad Institute
• Daniel MacArthur, CPG/Genomes/gnomAD
Beyond the Read: Integrating Long-Read Data into the Clinical Variant Pipeline
• Chair: Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee P. Ji, Stanford
DNA to FDA: How Genetic Targets Win Labels & Coverage
• Russ B. Altman, Stanford
Common Diseases in Clinical Cohorts – Not Always What They Seem
• Howard J. Jacob, Abbvie
DNA to FDA: How Genetic Targets Win Labels & Coverage
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Russ B. Altman, Stanford
25+ Years of the Human Genome — What Made It to the Bedside
• Chair: Ralph Snyderman, Duke
• J. Craig Venter, Craig Venter Institute (JCVI)
• Brook Byers, KPCB
• Lee Hood, Phenome Health
